Pharmaceutical Executive Digest Europe - January 14, 2009 - (Page 2) News Chandler Chicco Named Healthcare Consultancy of the Year Chandler Chicco Companies (CCC) has been named European Healthcare Consultancy of the Year 2008 by The Holmes Report, a leading resource for corporate communications, public relations professionals and journalists. CCC was awarded the accolade for its “evolution and diversity strategy.” CCC works on a total of 70 brands from its London and Paris offices and through its affiliate network. The company is made up of four individual organizations: Chandler Chicco Agency, a communications agency; Litmus, which provides medical education services; Biosector 2, which specialises in the biotechnology and specialty pharmaceuticals sectors; and Brandtectonics, a new unit focused on helping clients explore, explain and reinforce the value of their products. For more on these news stories and all the latest breaking pharma news, look at our website www.pharmexeceurope.com Merck strikes a deal with PPD Pharmaceutical Product Development (PPD, US) is entering into a strategic collaboration with Merck centred on vaccine testing and assay development. Under the terms of the agreement, PPD purchased Merck’s 130,000 square foot vaccine testing laboratory in Wayne, Pennsylvania, US, and hired 80 Merck professionals to run the facility. PPD will provide assay development and immunogenicity testing services to support Merck’s vaccine portfolio, in addition to providing traditional central laboratory and sample storage service to Merck over a five year period. “We believe strategic outsourcing is key to the future of R&D and represents an innovative approach to the challenges facing our pharmaceutical and biotechnology clients,” commented Fred Eshelman, CEO of PPD. “This collaboration with Merck represents a unique opportunity for us to acquire leading scientific talent and state-ofthe-art facilities, expand an existing relationship with a long-time client and offer a new service line to other customers in the growing vaccine market.” Financial details of the deal have not been disclosed. GSK to stop political donations GlaxoSmithKline (GSK) has said that it will no longer make political donations. GSK chief executive Andrew Witty, although careful to point out that all GSK donations in the past have followed the letter of the law, stated the company wants to be as open as possible in its dealings with governments. “As part of our overall drive to improve transparency in terms of our interactions with governments, political leaders and candidates for public office, we believe that stopping corporate political contributions is the right thing to do.” The Chandler Chicco team 4 BRUSSELS REPORT Setbacks for patient communication in Europe 5 FROM THE EDITOR New year, new format 6 EXECUTIVE PROFILE Nycomed’s Håkan Bjorklünd 9 Q&A Singapore Economic Development Board http://www.pharmexeceurope.com
Table of Contents Feed for the Digital Edition of Pharmaceutical Executive Digest Europe - January 14, 2009 Pharmaceutical Executive Digest Europe - January 14, 2009 Contents News Brussels Report From the Editor Executive Profile Q&A Strategy Fundamentals Calendar Pharmaceutical Executive Digest Europe - January 14, 2009 Pharmaceutical Executive Digest Europe - January 14, 2009 - Contents (Page 1) Pharmaceutical Executive Digest Europe - January 14, 2009 - News (Page 2) Pharmaceutical Executive Digest Europe - January 14, 2009 - News (Page 3) Pharmaceutical Executive Digest Europe - January 14, 2009 - Brussels Report (Page 4) Pharmaceutical Executive Digest Europe - January 14, 2009 - From the Editor (Page 5) Pharmaceutical Executive Digest Europe - January 14, 2009 - Executive Profile (Page 6) Pharmaceutical Executive Digest Europe - January 14, 2009 - Executive Profile (Page 7) Pharmaceutical Executive Digest Europe - January 14, 2009 - Executive Profile (Page 8) Pharmaceutical Executive Digest Europe - January 14, 2009 - Q&A (Page 9) Pharmaceutical Executive Digest Europe - January 14, 2009 - Q&A (Page 10) Pharmaceutical Executive Digest Europe - January 14, 2009 - Strategy Fundamentals (Page 11) Pharmaceutical Executive Digest Europe - January 14, 2009 - Strategy Fundamentals (Page 12) Pharmaceutical Executive Digest Europe - January 14, 2009 - Calendar (Page 13)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.